...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

Vetter’s Dr. Claudia Roth is Appointed to the Fraunhofer Advisory Board

| Print |
Tuesday, 28 March 2017 16:05 (UTC + 2)

Vetter logo

Appointment will allow for active involvement within the Fraunhofer Institute for Manufacturing Engineering and Automation IPA

Ravensburg, Germany, March 28, 2017 / B3C newswire / -- Dr. Claudia Roth, Vice President for Vetter’s department of Innovation Management, has been appointed to the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart. Over the next two years, Dr. Roth will be active in the Process Industry business unit.

Cooperation among scientific research organizations, such as Germany’s preeminent Fraunhofer-Gesellschaft, is an integral part of Vetter's innovation management. “Sharing information with the sciences offers significant stimuli, particularly in the field of manufacturing,” said Dr. Roth. “This appointment is particularly exciting since it allows me to contribute knowledge I gained as a member of the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA.” The IPA’s Process Industry business unit researches how programs such as Industry 4.0 can be applied to processes in the pharmaceutical sector.

The fact that Vetter's innovation manager is discussing such issues with members of the IPA Advisory Board is valuable for both Vetter and the Fraunhofer-Gesellschaft. Commenting on the appointment, Dr. Michael Hilt, deputy head of Fraunhofer IPA in Stuttgart said: “Dr. Roth’s years of experience will help us better focus our development and solutions on the corporate needs of the process industry.”

Vetter is currently working on securing its future due to a 360-degree process involving internal and external impulses to find new incitements. The ideas are integrated in a multi-stage innovation process which starts with a potential appraisal and ends with the possible market launch. The focus is on new manufacturing processes and technologies, additional services and innovative application systems to increase customer value.

Dr. Claudia Roth, who holds a diploma in Process engineering, has been with Vetter since many years. As a specialist in development she has played a major role in setting up the Vetter Development Service. She also headed up Vetter Development Service Chicago, USA, from 2009 to 2014.

Claudia Roth

Caption: Dr. Claudia Roth, Vetter Vice President Innovation Management has been named as a member of the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart, and is active in the Process Industry business unit.
Source: Vetter Pharma International GmbH
For high resolution please click the image.

 
About Vetter
Vetter is a global leader in the fill and finish of aseptically prefilled syringe systems, cartridges and vials. Headquartered in Ravensburg, Germany, the company operates production facilities in Germany and the United States, as well as sales offices in Singapore and Tokyo, Japan. The contract development and manufacturing organization (CDMO) is an innovative solution provider serving small, midsize, and the top 10 (bio-)pharmaceutical companies. Its portfolio spans state-of-the-art manufacturing from early clinical development through commercial filling and final packaging of parenteral drugs. Known for quality, the company of approximately 4,100 employees offers a foundation of experience spanning more than 35 years, including dozens of customer product approvals for novel compounds. More than 80% of Vetter’s active projects are biologics, and Vetter currently manufactures five of the world’ top 10. The CDMO is also committed to patient safety and compliance with user friendly solutions such as Vetter-Ject®, as well as its dual-chamber syringe Vetter Lyo-Ject® and cartridge system V-LK®.

About Fraunhofer IPA
With nearly 1 000 employees, the Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Fraunhofer IPA, is one of the largest institutes in the Fraunhofer-Gesellschaft. It has an annual budget of approximately 64,2 million euros, of which more than one third derives from industrial projects. The institute’s research focus is on organizational and technological aspects of production. We develop, test and implement not only components, devices and methods, but also entire machines and manufacturing plants. Our 14 departments are coordinated via six business units, which together conduct interdisciplinary work with the following industries: automotive, machinery and equipment industry, electronics and microsystems, energy, medical engineering and biotechnology as well as process industry. The research activities of Fraunhofer IPA aim at the economic production of sustainable and personalized products. We regard cyber-physical production processes as topics of the future.


Contact

Vetter Pharma International GmbH
Markus Kirchner
Corporate Spokesperson / Specialist External Communications
Eywiesenstrasse 5
88212 Ravensburg
Germany
+49 (0)751-3700-3729
This e-mail address is being protected from spambots. You need JavaScript enabled to view it